Skip to main content
AAN.com
Brief Communications
January 23, 2001

SPECT imaging of the dopamine transporter in juvenile-onset dystonia

January 23, 2001 issue
56 (2) 266-267

Abstract

Juvenile-onset dystonia that improves after levodopa may occur in both dopa-responsive dystonia (DRD) and juvenile parkinsonism (JP), clinically similar conditions with different prognoses and management goals. The authors show normal striatal uptake of the dopamine transporter ligand FP-CIT with SPECT in a clinically atypical case of DRD, in contrast to the reduced uptake observed in JP.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Furukawa Y, Kish SJ. Dopa-responsive dystonia: recent advances and remaining issues to be addressed. Mov Disord . 1999; 14: 709–715.
2.
Booij J, Tissingh G, Boer GJ, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry . 1997; 62: 133–140.
3.
Hyland K, Fryburg JS, Wilson WG, et al. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology . 1997; 48: 1290–1297.
4.
Sawle GV, Leenders KL, Brooks DJ, et al. Dopa-responsive dystonia: [18F]dopa positron emission tomography. Ann Neurol . 1991; 30: 24–30.
5.
Booij J, Rijk-van Andel F, Noorden PJ, Wevers RA. No loss of striatal dopamine transporters and D2 receptors in patients with autosomal recessive dopa-responsive dystonia. J Nucl Med . 1999; 40 (suppl): 272.Abstract.
6.
Naumann M, Pirker W, Reiners K, Lange K, Becker G, Brucke T. [123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia. Mov Disord . 1997; 12: 448–451.
7.
Jeon BS, Jeong JM, Park SS, et al. Dopamine transporter density measured by [I-123]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol . 1998; 43: 792–800.
8.
O’Sullivan JD, Costa DC, Lees AJ. Confirming Parkinson’s disease with 123I-FP-CIT SPECT. Eur J Neurol . 1999; 6 (suppl 3): 131.Abstract.

Information & Authors

Information

Published In

Neurology®
Volume 56Number 2January 23, 2001
Pages: 266-267
PubMed: 11160970

Publication History

Received: June 1, 2000
Accepted: September 28, 2000
Published online: January 23, 2001
Published in print: January 23, 2001

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

John D. O’Sullivan, MD
From the Reta Lila Weston Institute of Neurological Studies (Drs. O’Sullivan and Lees) and the Institute of Nuclear Medicine (Drs. Costa and Gacinovic), Royal Free and University College Medical School, University College London, UK.
Durval C. Costa, MD
From the Reta Lila Weston Institute of Neurological Studies (Drs. O’Sullivan and Lees) and the Institute of Nuclear Medicine (Drs. Costa and Gacinovic), Royal Free and University College Medical School, University College London, UK.
Svetislav Gacinovic, MD
From the Reta Lila Weston Institute of Neurological Studies (Drs. O’Sullivan and Lees) and the Institute of Nuclear Medicine (Drs. Costa and Gacinovic), Royal Free and University College Medical School, University College London, UK.
Andrew J. Lees, MD
From the Reta Lila Weston Institute of Neurological Studies (Drs. O’Sullivan and Lees) and the Institute of Nuclear Medicine (Drs. Costa and Gacinovic), Royal Free and University College Medical School, University College London, UK.

Notes

Address correspondence and reprint requests to Professor Andrew J. Lees, Reta Lila Weston Institute of Neurological Studies, Royal Free and University College Medical School, Windeyer Building, 46 Cleveland Street, London, W1P 6DB, UK; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Dopa-Responsive Dystonia and Related Disorders, Movement Disorder Emergencies, (421-454), (2021).https://doi.org/10.1007/978-3-030-75898-1_24
    Crossref
  2. Combined dystonias: clinical and genetic updates, Journal of Neural Transmission, 128, 4, (417-429), (2020).https://doi.org/10.1007/s00702-020-02269-w
    Crossref
  3. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice, Parkinsonism & Related Disorders, 21, 2, (87-94), (2015).https://doi.org/10.1016/j.parkreldis.2014.11.007
    Crossref
  4. Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia, Brain, 138, 5, (e351-e351), (2014).https://doi.org/10.1093/brain/awu325
    Crossref
  5. Neuroimaging in dystonia, Handbook of Dystonia, (101-113), (2012).https://doi.org/10.3109/9781841848525.007
    Crossref
  6. Dopa-Responsive Dystonia, Movement Disorder Emergencies, (319-340), (2012).https://doi.org/10.1007/978-1-60761-835-5_24
    Crossref
  7. Dopa-responsive dystonia, Hyperkinetic Movement Disorders, (539-557), (2011).https://doi.org/10.1016/B978-0-444-52014-2.00039-2
    Crossref
  8. Neuroimaging in Dystonia, Handbook of Dystonia, (93-106), (2010).https://doi.org/10.3109/9781420019988.007
    Crossref
  9. PATIENT MANAGEMENT PROBLEM, CONTINUUM: Lifelong Learning in Neurology, 14, (182-193), (2008).https://doi.org/10.1212/01.CON.0000275636.61709.8c
    Crossref
  10. Smoking‐responsive juvenile‐onset Parkinsonism, Movement Disorders, 22, 1, (115-119), (2007).https://doi.org/10.1002/mds.21177
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share